Treatment of hypertension with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and resting metabolic rate: A cross-sectional study
The Journal of Clinical Hypertension Dec 06, 2021
Pedrianes-Martin PB, Martin-Rincon M, Morales-Alamo D, et al. - Treatment with antihypertensive medications that antagonize the renin-angiotensin system may confer normalization of elevated resting metabolic rate (RMR) per kg of lean body mass (LBM).
Hypertension in obese and overweight patients is linked with an increased RMR.
Participants were 174 volunteers; 93 (46.5 %) with hypertension, of which 16 men and 13 women were treated with angiotensin-converting enzyme inhibitors (ACEI)/angiotensin blockers (ARB), while 30 men and 19 women with untreated hypertension formed the control group.
Compared with ACEI/ARB-treated hypertensive women, the untreated ones exhibited 15% higher RMR normalized to the LBM.
Patients taking ACEI/ARB had 2.9% lower RMR, post-accounting for LBM, whole-body fat mass, age, the double product (heart rate x systolic blood pressure), and the distance walked per day.
Relative to males, untreated hypertensive overweight and obese females exhibited a greater RMR per kg of LBM, while this gender disparity was absent in patients treated with ACEI or ARBs.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries